SHANGHAI PHARMACEUTICALS HOLDING CO revenue breakdown overview

SHANGHAI PHARMACEUTICALS HOLDING CO revenue for the last year amounted to 275.25 B CNY, the most of which — 245.52 B CNY — came from its highest performing source at the moment, Distribution, the year earlier bringing 228.35 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI PHARMACEUTICALS HOLDING CO 270.22 B CNY, and the year before that — 255.97 B CNY.